The inaugural Pharma West Africa Exhibition and Conference, held from March 20th to 22nd at the Landmark Centre in Lagos, Nigeria, witnessed a gathering of over 150 pharmaceutical companies. The event served as a platform for these companies to showcase their products and services to a diverse audience of pharmaceutical professionals from across West Africa.
The esteemed event was chaired by His Excellency, Pharm. Ahmed Yakasai, mni, (Kachallan), the Former Commissioner for Commerce and Tourism, Kano state, lent his expertise and leadership to the proceedings.
Among the notable participants was Prof. Martins Emeje, the Director General of the Nigeria Natural Medicine Development Agency (NNMDA), a distinguished figure in the pharmaceutical industry. Prof. Emeje, a Fellow of the African Academy of Sciences (FAAS) and a Fellow of the Pharmaceutical Society of Nigeria (FPSN) seized the opportunity to emphasize the importance of indigenous medicine development and local drug manufacturing.
The presence of Prof. Emeje and other esteemed speakers facilitated invaluable discussions and knowledge sharing, fostering collaboration and networking among professionals in the sub-region. Prof. Emeje’s advocacy for indigenous medicine development resonated strongly with attendees, reaffirming the significance of embracing traditional knowledge in the advancement of healthcare.
The Pharma West Africa Exhibition and Conference catalyzed industry growth, providing a fertile ground for exploring new opportunities and strategies to enhance pharmaceutical practices in the region. With a focus on indigenous medicine and local drug manufacturing, the event underscored the importance of leveraging indigenous knowledge to address contemporary healthcare challenges.
As the pharmaceutical landscape continues to evolve, events like the Pharma West Africa Exhibition and Conference play a pivotal role in driving innovation, collaboration, and progress within the industry. The insights shared by Prof. Martins Emeje and other industry leaders are poised to shape the future of pharmaceutical practices in West Africa and beyond.
